{"id":"https://openalex.org/W4393095474","doi":"https://doi.org/10.1158/1538-7445.am2024-4669","title":"Abstract 4669: Differential preclinical activity of Bruton tyrosine kinase inhibitors (BTKis) against BTK resistance-associated mutations","display_name":"Abstract 4669: Differential preclinical activity of Bruton tyrosine kinase inhibitors (BTKis) against BTK resistance-associated mutations","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393095474","doi":"https://doi.org/10.1158/1538-7445.am2024-4669"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-4669","doi":"https://doi.org/10.1158/1538-7445.am2024-4669","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-4669","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063755644","display_name":"Matthew Steven Davids","orcid":"https://orcid.org/0000-0003-4529-2003","observed_orcids":["https://orcid.org/0000-0003-4529-2003"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew S. Davids","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055037645","display_name":"Inhye E. Ahn","orcid":"https://orcid.org/0000-0003-3717-287X","observed_orcids":["https://orcid.org/0000-0003-3717-287X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Inhye E. Ahn","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049396577","display_name":"Jacob Riehm","orcid":"https://orcid.org/0009-0005-3998-1656","observed_orcids":["https://orcid.org/0009-0005-3998-1656"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob J. Riehm","raw_affiliation_strings":["2AbbVie, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080683479","display_name":"Melih Acar","orcid":"https://orcid.org/0000-0003-0891-9508","observed_orcids":["https://orcid.org/0000-0003-0891-9508"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melih Acar","raw_affiliation_strings":["2AbbVie, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012179432","display_name":"Vincent Girardi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vincent Girardi","raw_affiliation_strings":["2AbbVie, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003885947","display_name":"Sima Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sima Patel","raw_affiliation_strings":["2AbbVie, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031007480","display_name":"Tarikere L. Gururaja","orcid":"https://orcid.org/0000-0003-2684-2647","observed_orcids":["https://orcid.org/0000-0003-2684-2647"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tarikere Gururaja","raw_affiliation_strings":["2AbbVie, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014241029","display_name":"Jennifer Ann Woyach","orcid":"https://orcid.org/0000-0002-3403-9144","observed_orcids":["https://orcid.org/0000-0002-3403-9144"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Woyach","raw_affiliation_strings":["3Ohio State University Comprehensive Cancer Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Ohio State University Comprehensive Cancer Center, Columbus, OH","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I2802841970","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034213336","display_name":"Lloyd T. Lam","orcid":"https://orcid.org/0000-0002-8252-5753","observed_orcids":["https://orcid.org/0000-0002-8252-5753"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lloyd T. Lam","raw_affiliation_strings":["2AbbVie, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035122840","display_name":"Edith Szafer\u2010Glusman","orcid":"https://orcid.org/0000-0002-5720-881X","observed_orcids":["https://orcid.org/0000-0002-5720-881X"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edith Szafer-Glusman","raw_affiliation_strings":["2AbbVie, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"4669","last_page":"4669"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9800000190734863},{"id":"https://openalex.org/keywords/acalabrutinib","display_name":"acalabrutinib","score":0.9779999852180481},{"id":"https://openalex.org/keywords/zanubrutinib","display_name":"zanubrutinib","score":1.0},{"id":"https://openalex.org/keywords/pirtobrutinib","display_name":"pirtobrutinib","score":1.0},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.8700000047683716},{"id":"https://openalex.org/keywords/relapsed-refractory-cll","display_name":"relapsed/refractory CLL","score":0.8270000219345093},{"id":"https://openalex.org/keywords/kinase-inhibition","display_name":"kinase inhibition","score":0.43799999356269836},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.9625165462493896},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6276358962059021},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5460744500160217},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5283803939819336},{"id":"https://openalex.org/C93226319","wikidata":"https://www.wikidata.org/wiki/Q193137","display_name":"Differential (mechanical device)","level":2,"score":0.4479522109031677},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34464138746261597},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29802030324935913},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.04372125864028931},{"id":"https://openalex.org/C97355855","wikidata":"https://www.wikidata.org/wiki/Q11473","display_name":"Thermodynamics","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-4669","doi":"https://doi.org/10.1158/1538-7445.am2024-4669","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-4669","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.979200005531311,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4406364655","https://openalex.org/W4409631825","https://openalex.org/W28090229","https://openalex.org/W2047415399","https://openalex.org/W3174989354","https://openalex.org/W2991578543","https://openalex.org/W7044083757","https://openalex.org/W4379983983","https://openalex.org/W4389235362","https://openalex.org/W4404372816"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Differences":[2],"in":[3,48,63,100,207,213,229,291],"profiles":[4],"of":[5,8,22,45,56,84,91,225,246,294,300,306,381,394],"acquired":[6],"mutations":[7,38,271,390],"resistance":[9,257],"to":[10,94,204,227,258,273],"BTKis":[11,23,60,307],"might":[12],"have":[13],"implications":[14],"for":[15,128,278,289,398],"treatment":[16,293],"sequencing.":[17],"We":[18],"evaluated":[19,62,99,250],"preclinical":[20,379],"activity":[21,58,67,71,125,161,169,245,305,380],"(ibrutinib":[24],"[Ibr],":[25],"acalabrutinib":[26],"[Acala],":[27],"zanubrutinib":[28],"[Zanu],":[29],"and":[30,39,147,176,183,185,192,212,236,260,311],"pirtobrutinib":[31],"[Pirto])":[32],"against":[33,135,162,174,180,188,248,308,387],"multiple":[34],"clinically":[35],"relevant":[36],"BTK":[37,46,74,165,251,301,313,316,388],"report":[40],"on":[41,72],"the":[42,292,395],"clinical":[43,119,205],"impact":[44],"C481S":[47,92,136,175,200,226,270,319],"patients":[49],"(pts)":[50],"treated":[51,102,197],"with":[52,103,105,131,172,178,186,198,216,256,296],"Ibr.":[53],"Methods:":[54],"Inhibition":[55],"kinase":[57,66,124,384],"by":[59],"was":[61,79,98,126,170,201,232],"a":[64,287,297],"cell-free":[65],"assay":[68],"(Nanosyn).":[69],"Cell-killing":[70,304],"CRISPR-generated":[73],"mutant":[75,312],"knock-in":[76],"TMD8":[77],"cells":[78],"assessed":[80],"after":[81],"3":[82,208],"days":[83],"BTKi":[85],"treatment.":[86],"Time":[87],"from":[88,117,222,276],"first":[89,223],"detection":[90,224],"mutation":[93],"progressive":[95],"disease":[96],"(PD)":[97],"pts":[101,196,211,215,231,267,295],"Ibr":[104,129,158,247,277,290,324],"previously":[106,209],"untreated":[107,210],"(n=247)":[108],"or":[109,133],"relapsed/refractory":[110],"(R/R;":[111],"n=172)":[112],"CLL":[113],"using":[114],"pooled":[115],"data":[116,264,285],"5":[118],"trials.":[120],"Results:":[121],"In":[122,195],"vitro":[123],"highest":[127],"compared":[130],"Acala":[132,173,331],"Zanu":[134,179,338],"(Ibr":[137],"IC50:":[138],"26.3":[139],"nM;":[140,143,151,154],"Zanu:":[141,152],"84.8":[142],"Acala:":[144,155],"338":[145],"nM)":[146],"T474I":[148,320],"(Ibr:":[149],"1.2":[150],"4.4":[153],"43.6":[156],"nM).":[157],"maintained":[159],"cell-killing":[160],"all":[163,249],"tested":[164],"mutants,":[166],"whereas":[167],"limited":[168],"seen":[171],"A428D;":[177,184],"C481S,":[181],"L528W,":[182,190],"Pirto":[187,345],"T474I,":[189],"V416L,":[191],"A428D":[193,323],"(Table).":[194],"Ibr,":[199],"detected":[202],"prior":[203],"PD":[206,228],"26":[214],"R/R":[217],"CLL;":[218],"median":[219],"(range)":[220],"time":[221],"these":[230,284],"17.0":[233],"mo":[234,238],"(11.2-34.3)":[235],"10.0":[237],"(2.6-35.7),":[239],"respectively.":[240],"Conclusion:":[241],"This":[242],"study":[243],"demonstrates":[244],"variants,":[252],"which":[253],"are":[254],"associated":[255],"covalent":[259],"noncovalent":[261],"BTKis.":[262],"Clinical":[263],"shows":[265],"that":[266],"who":[268],"develop":[269],"continue":[272],"derive":[274],"benefit":[275],"several":[279],"months":[280],"before":[281],"PD.":[282],"Together,":[283],"suggest":[286],"role":[288],"broad":[298],"spectrum":[299],"variants.":[302],"Table.":[303],"wild":[309],"type":[310,318],"EC50":[314],"(nM)":[315],"Wild":[317],"L528W":[321],"V416L":[322],"0.6":[325,343],"414.0":[326],"1.9":[327],"181.4":[328],"0.5":[329],"205.3":[330],"3.9":[332],"2973.8":[333],"43.3":[334],"3.5":[335],"106.3":[336],"3000.0":[337,342,349,351],"0.7":[339],"2322.0":[340],"11.7":[341],"1726.0":[344],"8.2":[346],"12.6":[347],"2727.5":[348],"1898.0":[350],"Citation":[352],"Format:":[353],"Matthew":[354],"S.":[355],"Davids,":[356],"Inhye":[357],"E.":[358],"Ahn,":[359],"Jacob":[360],"J.":[361],"Riehm,":[362],"Melih":[363],"Acar,":[364],"Vincent":[365],"Girardi,":[366],"Sima":[367],"Patel,":[368],"Tarikere":[369],"Gururaja,":[370],"Jennifer":[371],"Woyach,":[372],"Lloyd":[373],"T.":[374],"Lam,":[375],"Edith":[376],"Szafer-Glusman.":[377],"Differential":[378],"Bruton":[382],"tyrosine":[383],"inhibitors":[385],"(BTKis)":[386],"resistance-associated":[389],"[abstract].":[391],"In:":[392],"Proceedings":[393],"American":[396],"Association":[397],"Cancer":[399,417],"Research":[400],"Annual":[401],"Meeting":[402],"2024;":[403],"Part":[404],"1":[405],"(Regular":[406],"Abstracts);":[407],"2024":[408],"Apr":[409],"5-10;":[410],"San":[411],"Diego,":[412],"CA.":[413],"Philadelphia":[414],"(PA):":[415],"AACR;":[416],"Res":[418],"2024;84(6_Suppl):Abstract":[419],"nr":[420],"4669.":[421]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-03-23T00:00:00"}